• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Findings: Treatment-resistant hypertension exerts serious emotional toll on patients

Findings: Treatment-resistant hypertension exerts serious emotional toll on patients

March 5, 2013
CenterWatch Staff

Results from a large, international survey on treatment-resistant hypertension (rHTN) found rHTN has a significant impact on patients' quality of life, having a negative impact on mood, work and interpersonal relationships.

These findings underscore the critical need to more aggressively educate and empower patients and healthcare professionals to help improve control of rHTN. The survey results were published in the Journal of Hypertension, the official journal of the International Society of Hypertension and the European Society of Hypertension.

Nearly 120 million people worldwide suffer with rHTN, defined as persistently high blood pressure despite treatment with three or more antihypertensive medications. Treatment-resistant hypertension is caused by multiple factors, including lifestyle and underlying conditions, making its diagnosis and management complex, often requiring a multi-disciplinary approach. Patients with rHTN have a three-fold increase in risk of cardiovascular events, including stroke and heart attack, compared to individuals with controlled hypertension.

To better understand this growing population of at-risk patients, Power Over Pressure, a coalition of global hypertension experts endorsed by the American Society of Hypertension and the European Society of Hypertension, commissioned a global study of uncontrolled hypertension patients, half of whom are treatment-resistant. The survey was conducted online in October, 2011 by Harris Interactive among more than 4,500 uncontrolled hypertension patients in Brazil, France, Germany, Italy, Japan, Spain, the U.K. and the U.S. 

The survey results showed people with rHTN are very worried about their overall health. Although most reported being under the care of a general practitioner or cardiologist, 67% described their overall health as 'fair or poor.' Patients said their blood pressure negatively affects their mood (25%), sex life (32%) and self-esteem (29%). Furthermore, 75% said their quality of life would greatly improve if they could get their blood pressure under control.

"Treatment-resistant hypertension takes a significant toll on a person's quality of life, both physically and emotionally. It can be a very frustrating condition to manage for both patients and their physicians," said Roland Schmieder, M.D., professor at the University Hospital Erlangen in Germany and co-chair of the Power Over Pressure steering committee.

For patients with rHTN, the condition is clearly their most serious health concern and it has a profound impact on their everyday lives. Fifty-seven percent reported they are often anxious about managing their blood pressure and 41% reported feeling powerless to control their high blood pressure. When asked about their doctor's attitude about their hypertension, 32% felt their doctor underestimates how much their high blood pressure impacts their life.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing